Financials

  • Market Capitalization 35.94 M
  • Employee 1 178
  • Founded 2012
  • CEO Serge Saxonov
  • Website www.10xgenomics.com
  • Headquarter Delaware, United States
  • FIGI BBG007WX14X0
  • Industry Services d'Information sur la Santé
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-46.6
ratio cours/chiffre d'affaires
3.17

10x Genomics, Inc. - Common Stock

10x Genomics, Inc. is an American biotechnology company that designs and manufactures sequencing technologies for use in scientific research, with a focus on product development for single-cell and spatial omics.

Nouvelles